Report - INDEPENDENT RESEARCH Novartis · INDEPENDENT RESEARCH. Novartis . 30th October 2012 . Ophthalmology : A growth avenue . Healthcare. BUY. Fair Value CHF62 vs. 61 (price CHF56.80) Bloomberg

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form